232 related articles for article (PubMed ID: 25266870)
21. MALDI-TOF mass spectrometry: An emerging tool for unequivocal identification of non-fermenting Gram-negative bacilli.
Gautam V; Sharma M; Singhal L; Kumar S; Kaur P; Tiwari R; Ray P
Indian J Med Res; 2017 May; 145(5):665-672. PubMed ID: 28948958
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry for species identification of nonfermenting Gram-negative bacilli.
Almuzara M; Barberis C; Traglia G; Famiglietti A; Ramirez MS; Vay C
J Microbiol Methods; 2015 May; 112():24-7. PubMed ID: 25765149
[TBL] [Abstract][Full Text] [Related]
23. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.
Capaldo C; Beauruelle C; Saliou P; Rault G; Ramel S; Héry-Arnaud G
Respir Med Res; 2020 Nov; 78():100757. PubMed ID: 32759054
[TBL] [Abstract][Full Text] [Related]
24. Comparison of matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry platforms for the identification of gram-negative rods from patients with cystic fibrosis.
Alby K; Gilligan PH; Miller MB
J Clin Microbiol; 2013 Nov; 51(11):3852-4. PubMed ID: 23966494
[TBL] [Abstract][Full Text] [Related]
25. Comparative Whole-Genome Phylogeny of Animal, Environmental, and Human Strains Confirms the Genogroup Organization and Diversity of the Stenotrophomonas maltophilia Complex.
Mercier-Darty M; Royer G; Lamy B; Charron C; Lemenand O; Gomart C; Fourreau F; Madec JY; Jumas-Bilak E; Decousser JW
Appl Environ Microbiol; 2020 May; 86(10):. PubMed ID: 32198168
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis.
Talmaciu I; Varlotta L; Mortensen J; Schidlow DV
Pediatr Pulmonol; 2000 Jul; 30(1):10-5. PubMed ID: 10862157
[TBL] [Abstract][Full Text] [Related]
27. Analyses of black fungi by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS): species-level identification of clinical isolates of Exophiala dermatitidis.
Kondori N; Erhard M; Welinder-Olsson C; Groenewald M; Verkley G; Moore ER
FEMS Microbiol Lett; 2015 Jan; 362(1):1-6. PubMed ID: 25790495
[TBL] [Abstract][Full Text] [Related]
28. Genotypic and Phenotypic Characterization of Stenotrophomonas maltophilia Strains from a Pediatric Tertiary Care Hospital in Serbia.
Madi H; Lukić J; Vasiljević Z; Biočanin M; Kojić M; Jovčić B; Lozo J
PLoS One; 2016; 11(10):e0165660. PubMed ID: 27798695
[TBL] [Abstract][Full Text] [Related]
29. Outbreak of Stenotrophomonas maltophilia on an intensive care unit.
Guyot A; Turton JF; Garner D
J Hosp Infect; 2013 Dec; 85(4):303-7. PubMed ID: 24148363
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
31. Use of matrix assisted laser desorption ionisation-time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients.
Desai AP; Stanley T; Atuan M; McKey J; Lipuma JJ; Rogers B; Jerris R
J Clin Pathol; 2012 Sep; 65(9):835-8. PubMed ID: 22639406
[TBL] [Abstract][Full Text] [Related]
32. An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia.
Gherardi G; Creti R; Pompilio A; Di Bonaventura G
Diagn Microbiol Infect Dis; 2015 Mar; 81(3):219-26. PubMed ID: 25592000
[TBL] [Abstract][Full Text] [Related]
33. Clinical associations with carriage of pulmonary
Watson L; Priestley L; Chapman SJ; Andersson MI; Jeffery K; Flight WG
J R Coll Physicians Edinb; 2022 Mar; 52(1):14-19. PubMed ID: 36146962
[TBL] [Abstract][Full Text] [Related]
34. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
Lobo LJ; Tulu Z; Aris RM; Noone PG
Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
[TBL] [Abstract][Full Text] [Related]
35. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis.
Dalbøge CS; Hansen CR; Pressler T; Høiby N; Johansen HK
J Cyst Fibros; 2011 Sep; 10(5):318-25. PubMed ID: 21463972
[TBL] [Abstract][Full Text] [Related]
36. Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry.
Frost F; Nazareth D; Shaw M; Walshaw MJ
J Cyst Fibros; 2019 Mar; 18(2):294-298. PubMed ID: 30741162
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Achromobacter Species in Cystic Fibrosis Patients: Comparison of bla(OXA-114) PCR Amplification, Multilocus Sequence Typing, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
Rodrigues ER; Ferreira AG; Leão RS; Leite CC; Carvalho-Assef AP; Albano RM; Marques EA
J Clin Microbiol; 2015 Dec; 53(12):3894-6. PubMed ID: 26400790
[TBL] [Abstract][Full Text] [Related]
38. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.
Waters V; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
J Cyst Fibros; 2013 Sep; 12(5):482-6. PubMed ID: 23294530
[TBL] [Abstract][Full Text] [Related]
39. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
Krzewinski JW; Nguyen CD; Foster JM; Burns JL
J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
[TBL] [Abstract][Full Text] [Related]
40. Rapid identification of Burkholderia cepacia complex species recovered from cystic fibrosis patients using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Lambiase A; Del Pezzo M; Cerbone D; Raia V; Rossano F; Catania MR
J Microbiol Methods; 2013 Feb; 92(2):145-9. PubMed ID: 23201483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
